Inspection Record

Voyant Beauty, Inc. — Health Canada Inspection Findings

Health CanadaInspected 2024-06-04 7 findingsOther quality systemEquipment and facilityRegulatory reporting and change controlDeviation, CAPA, and investigationComplaint and recall handlingStability and storage

View the regulator's official source The source document is always the basis for judgement.

Findings

1Other quality system

The implementation of a self-inspection program was inadequate.

2Equipment and facility

The maintenance of records was inadequate.

3Regulatory reporting and change control

The change control system was inadequate for ensuring changes are properly documented, evaluated, and/or approved.

4Deviation, CAPA, and investigation

Investigations into deviations, reports, and/or follow-up actions were inadequate.

5Equipment and facility

The maintenance of the premises was inadequate. The qualification and/or verification of utilities and/or support systems was inadequate.

6Complaint and recall handling

The assessment, recording, follow-up, and/or investigation of complaints and/or other information about potentially defective products was inadequate.

7Stability and storage

The temperature and/or humidity control was inadequate.

About this record

Extracted automatically from the document of the Health Canada inspection on 2024-06-04. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Other records for this company

Voyant Beauty, Inc. findings history — including this company's other documentsAll Health Canada findings Health Canada documents, 2024 Go to Findings search
Weekly Newsletter

Get new findings like these every Monday

Every Monday we email the week's new findings and actions from the FDA, EMA, Health Canada and MFDS. Each one links to its record on our site, where you'll find the regulator's original document. We'll also let you know when the site gains new features. Unsubscribe any time with one click.

See recent findings first

Sent every Monday · a confirmation email follows when you subscribe · unsubscribe from the footer of any email.